Literature DB >> 10639471

Phagocytosed Bordetella pertussis fails to survive in human neutrophils.

D H Lenz1, C L Weingart, A A Weiss.   

Abstract

Previous studies have reported that phagocytosed Bordetella pertussis survives in human neutrophils. This issue has been reexamined. Opsonized or unopsonized bacteria expressing green fluorescent protein (GFP) were incubated with adherent human neutrophils. Phagocytosis was quantified by fluorescence microscopy, and the viability of phagocytosed bacteria was determined by colony counts following treatment with polymyxin B to kill extracellular bacteria. Only 1 to 2% of the phagocytosed bacteria remained viable. Opsonization with heat-inactivated immune serum reduced the amount of attachment and phagocytosis of the bacteria but did not alter survival rates. In contrast to previous reports, these data suggest that phagocytosed B. pertussis bacteria are killed by human neutrophils.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639471      PMCID: PMC97230          DOI: 10.1128/IAI.68.2.956-959.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Uptake and intracellular survival of Bordetella pertussis in human macrophages.

Authors:  R L Friedman; K Nordensson; L Wilson; E T Akporiaye; D E Yocum
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 2.  Functional diversity of helper T lymphocytes.

Authors:  A K Abbas; K M Murphy; A Sher
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

3.  Bordetella pertussis induces apoptosis in macrophages: role of adenylate cyclase-hemolysin.

Authors:  N Khelef; A Zychlinsky; N Guiso
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

4.  Effects of recombinant human gamma interferon on intracellular survival of Bordetella pertussis in human phagocytic cells.

Authors:  D Torre; G Ferrario; G Bonetta; L Perversi; R Tambini; F Speranza
Journal:  FEMS Immunol Med Microbiol       Date:  1994-09

5.  Cloning and sequencing of a Bordetella pertussis serum resistance locus.

Authors:  R C Fernandez; A A Weiss
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

6.  Epithelial cell invasion and survival of Bordetella bronchiseptica.

Authors:  H Schipper; G F Krohne; R Gross
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

7.  Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells.

Authors:  C A Guzman; M Rohde; M Bock; K N Timmis
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

Review 8.  Th1 and Th2 in human diseases.

Authors:  S Romagnani
Journal:  Clin Immunol Immunopathol       Date:  1996-09

9.  Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.

Authors:  K Redhead; J Watkins; A Barnard; K H Mills
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model.

Authors:  K H Mills; A Barnard; J Watkins; K Redhead
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

View more
  18 in total

1.  Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.

Authors:  C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults.

Authors:  C L Weingart; W A Keitel; K M Edwards; A A Weiss
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.

Authors:  C L Weingart; P S Mobberley-Schuman; E L Hewlett; M C Gray; A A Weiss
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

4.  A dual fluorescence flow cytometric analysis of bacterial adherence to mammalian host cells.

Authors:  Bochiwe Hara-Kaonga; Thomas G Pistole
Journal:  J Microbiol Methods       Date:  2007-01-10       Impact factor: 2.363

5.  Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Kari Torkildsen Brandsdal; Bjørn Peter Berdal; Erja M Aleksandersen; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2007-05-16

6.  Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Merete Bolstad; Synne Sandbu; Hilde Bakke; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

7.  Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes.

Authors:  L M Schaeffer; A A Weiss
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

8.  Bordetella adenylate cyclase toxin is a unique ligand of the integrin complement receptor 3.

Authors:  Radim Osicka; Adriana Osickova; Shakir Hasan; Ladislav Bumba; Jiri Cerny; Peter Sebo
Journal:  Elife       Date:  2015-12-09       Impact factor: 8.140

9.  Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice.

Authors:  Charlotte Andreasen; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

10.  Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN.

Authors:  Kanna Nagamatsu; Asaomi Kuwae; Tadashi Konaka; Shigenori Nagai; Sei Yoshida; Masahiro Eguchi; Mineo Watanabe; Hitomi Mimuro; Shigeo Koyasu; Akio Abe
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.